CSU Animal Cancer Center

06/03/2026

Lucky to Live 💚 🍀

Lucky is a smiley 12-year-old Welsh Corgi, beloved by his family. Lucky was diagnosed with an oral mass and underwent surgery to remove the tumor. His family received a patient assistance grant to help cover the cost of his care. Lucky’s owner wrote –

“Lucky is doing great! I want to thank everyone for their financial help in this journey with him. It has meant so much to us, and words can't really express our gratitude for helping us!

“The staff have been terrific and understanding. Dr. Rodriguez provided the utmost care for Lucky. Again, thank you all for your kindness and concern for our doggy!!”

- Diane C., Lucky's Owner

With your support, we can ensure that pets like Lucky get a fighting chance. Give today: https://www.csuanimalcancercenter.org/give-to-patient-assistance/

06/02/2026

Happy Clinical Trials Tuesday! We are still looking for dogs with the diagnosis of soft tissue sarcoma for enrollment in a trial. This study is testing the safety and anti-cancer activity of a form of immunotherapy called CAR T cells that are targeting a protein that is expressed on the tumor cells. You can learn more about this study here: https://www.csuanimalcancercenter.org/clinical-trial/clinical-testing-of-canine-t-cells-engineered-to-target-osteosarcoma-and-soft-tissue-sarcoma-in-combination-with-oral-immunotherapy/

Clinical Testing of Canine T cells clinical trial at the Flint Animal Cancer Center at Colorado State University.

05/31/2026

Make a difference during 🐾 🔬

Cancer Research Month may be coming to an end, but the work to understand, treat, and ultimately outpace cancer never stops.

At the Flint Animal Cancer Center, every day is dedicated to advancing discoveries that improve outcomes for pets with cancer — and contribute to breakthroughs that benefit both veterinary and human medicine.

Help drive this work forward – make a gift today. Your support directly fuels research that leads to better diagnostics, more effective treatments, and renewed hope for families facing cancer.

Donate here: https://www.csuanimalcancercenter.org/give-to-research/

Thank you for being part of the effort to keep cancer research moving forward — all year long.

05/29/2026

Thanks, Vet Specialists, for sharing Oban's story! 💚👏

When 13-year-old Oban was diagnosed with oral malignant melanoma, his family turned to the veterinary oncology specialists at CSU Animal Cancer Center for guidance. Through access to innovative clinical trials and the expertise of Board-Certified Veterinary Oncologists, Oban received advanced treatment options that helped him continue enjoying outdoor adventures with his family.

Read the full story: https://buff.ly/pJdBLzo

05/29/2026

Hero: Dr. Duval 🦸‍♂️

Meet Dr. Dawn Duval, whose work in Molecular Oncology and Functional Genomics is helping unravel the genetic and cellular mechanisms behind cancer. Her research focuses on understanding how tumors grow, adapt, and respond to treatment – knowledge that is essential for developing more precise and effective therapies.

Join us in celebrating the researchers working every day to turn molecular insight into meaningful impact.

05/28/2026

Spotlight: Combination Mast Cell Tumor Treatment

Dr. Kristen Weishaar, Director of Clinical Trials at the FACC, is working to create better treatment options for dogs with mast cell tumors.

While surgery remains the mainstay of treatment for most MCT, a subset has a high potential for eventual recurrence and metastasis.

With funding from the Dr. Larry and Ann Laiks Charitable Trust, Dr. Weishaar launched a clinical trial studying a new combination therapy using the immunotherapy drug gilvetmab and the cancer treatment toceranib phosphate (TOC). The hope is that this approach will improve treatment response and offer a more effective option for dogs facing aggressive mast cell tumors.

Advancing treatment options and improving outcomes is the direct result of cancer research. We're grateful to all the researchers who innovate new ideas and push the bounds of what's possible.

05/27/2026

This National Cancer Research Month, we’re celebrating the people whose work turns curiosity into progress. 🧬

Dr. Amy MacNeill brings a uniquely powerful combination of clinical pathology expertise and research innovation to the fight against cancer.

In a field where precision matters and time is critical, Dr. MacNeill’s work helps turn complex biological signals into actionable knowledge – fueling the larger mission of advancing cancer research for both animals and people.

05/26/2026

Happy Clinical Trials Tuesday! Our clinical trial using CAR T cells for treatment for bone cancer that has spread to the lungs is still recruiting patients. CAR T cells are a form of immunotherapy that is used in people for a variety of cancer types, and we are just starting to learn about their utility in pets with cancer. More information about this study is available here: https://www.csuanimalcancercenter.org/clinical-trial/car-t-cell-immunotherapy-for-treatment-of-metastatic-osteosarcoma-in-dogs/

Patient Disease: Canine Osteosarcoma with Metastasis to the Lungs Study Name: CAR T cell Immunotherapy for Treatment of Metastatic Osteosarcoma in Dogs Purpose of the study: Primary Eligibility Criteria: Study Protocol: Owner Responsibilities: Financial Incentives: If you have further questions abou...

05/25/2026

This Memorial Day, we pause to honor the brave service members who gave their lives in defense of our country — and the loyal military working dogs who served beside them with courage, dedication, and unwavering companionship.

At the Flint Animal Cancer Center, we are grateful for the sacrifices made by both human and canine heroes.

As we remember those who served, we also recognize the families, handlers, veterinarians, and caregivers who continue to support these remarkable animals long after their service ends.

🇺🇸🐾

05/24/2026

Innovation in Action 🔬

The Cancer Plasticity and Phenotypic Modeling Lab is advancing cutting-edge research in cancer biology and precision medicine. Their work focuses on understanding how cancer cells change their identity and behavior, with the goal of developing better biomarkers and more targeted therapies that can improve outcomes for patients across species.

This cutting-edge comparative oncology research helps bridge veterinary and human medicine – turning insights from naturally occurring cancers in pets into discoveries that may benefit people as well.

Watch this video to learn more about their work: https://www.youtube.com/watch?v=EbjxrYW9RYg